Reaction
Gastrointestinal Viral Infection reporting signals
As of the last recalculation, Gastrointestinal Viral Infection appears in 1,028 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is HUMAN IMMUNOGLOBULIN G (PRR 30.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Human Immunoglobulin G | 30 | 30.3 | 30.3 |
| Basiliximab | 14 | 24.4 | 24.4 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 24 | 23.3 | 23.3 |
| Vigabatrin | 12 | 16.9 | 16.9 |
| Tranexamic Acid | 7 | 16.0 | 16.1 |
| Ganciclovir | 8 | 15.9 | 16.0 |
| Ganciclovir Sodium | 8 | 15.4 | 15.4 |
| Vedolizumab | 57 | 14.1 | 14.1 |
| Sirolimus | 9 | 13.6 | 13.6 |
| Teduglutide | 8 | 12.1 | 12.1 |
| Fludarabine Phosphate | 22 | 11.6 | 11.6 |
| Posaconazole Delayed-Release | 6 | 11.1 | 11.1 |
| Diroximel Fumarate | 6 | 10.2 | 10.3 |
| Palivizumab | 5 | 6.6 | 6.6 |
| Emicizumab | 3 | 4.9 | 4.9 |
| Dimethyl Fumarate | 25 | 4.2 | 4.2 |